DOSSIER · 13F-HR · Q1 2026

Samsara BioCapital, LLC

Samsara BioCapital's asset manager based in Greenwich, CT $1.0B in tracked AUM across 22 positions as of Q1 2026.

SB
Samsara BioCapital·Greenwich, CT·Asset Manager
CIK 0001744967 · last filed Mar 31, 2026
Total AUM
$1.0B
15.1%
vs prior
Holdings
22
positions
Whale Score
77
77
strong
Activity
no data
changes this Q
Top sector
Tech
8% weight
concentration
AI Analysis · Q1 2026 · Q1 2026

Based on the SEC 13F filing for the period ended September 30, 2025, here is a comprehensive analysis of Samsara BioCapital, LLC’s portfolio.

1. Portfolio Overview

Samsara BioCapital manages a highly concentrated, specialized investment portfolio with a total value of approximately $399.47 million. The firm’s strategy is characterized by high conviction in a limited number of assets, holding only 17 positions. This represents a significant consolidation and contraction in capital de...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
SRRK
SCHOLAR ROCK HLDG CORP
$339M6.9M32.9%
02
MLYS
MINERALYS THERAPEUTICS INC
$159M5.9M15.5%
03
ALMS
ALUMIS INC
$140M6.3M13.6%
04
SEPN
SEPTERNA INC
$76M3.1M7.4%
05
KLRS
KALARIS THERAPEUTICS INC
$75M12.9M7.3%
06
SGP
SPYGLASS PHARMA INC
$55M2.1M5.3%
07
NGNE
NEUROGENE INC
$35M1.7M3.4%
08
IVA
INVENTIVA SA
$29M5.2M2.8%
09
STRO
SUTRO BIOPHARMA INC
$26M1.1M2.6%
10
JBIO
JADE BIOSCIENCES INC
$14M969K1.3%

Filing history

Filing history loading…